NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









QureTech Bio

QureTech Bio

Private
UmeåHealthcare & Life Scienceshttps://quretech.com/

Last Round

VC Round

Sep 23, 2024

Total Funding Raised

$830,000

Company Overview

QureTech Bio is a biotechnology company developing new solutions to combat disease-causing bacteria and tackle antimicrobial resistance.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Revenue Share

AI Layer

Non-AI

Keywords

antimicrobial resistanceAMRantibacterial agentsdrug discoverysmall molecule drugspreclinical biotechanti-infectivesantibiotic pipelinesuperbugsbiotech licensingvirulence blockersMRSA treatmentresistance breakerbacterial disarmingGram-positive bacteria

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

QureTech Bio Comparables

Compare QureTech Bio with similar companies based on industry and business-model similarity.

QureTech Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

QureTech Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundSep 23, 2024
VC RoundOct 26, 2020
GrantApr 21, 2020
GrantDec 18, 2019
SeedOct 2, 2018

Key People

Founding team and executive leadership

Markus Thor

Chief Executive Officer

Executive Team

Annica Rönnbäck

Chief Operating Officer

Executive Team

QureTech Bio Investors

Notable investors and investment history

QureTech Bio investors
InvestorRounds
VinnovaGrant
SwelifeGrant
Erling-Persson FoundationGrant
Nascent InvestVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 16, 2024

    Monthly visitors grew 91% MoM, reaching 2.1K.

QureTech Bio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

QureTech Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about QureTech Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersUmeå
Employee Range8
Year FoundedN/A
Last FundingSep 23, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.